Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 4-hydroxy-3-phenylbutyric Acid Sodium Salt
2. Sodium 4-hydroxy-3-phenylbutanoate
3. 4zy84kzd7g
4. 40951-19-7
5. Beta-phenyl-gamma-oxybutyrate Sodium
6. Gamma-hydroxy-beta-phenylbutyrate Sodium
7. Butyric Acid, 4-hydroxy-3-phenyl-, Sodium Salt
8. Srisec127
9. Unii-4zy84kzd7g
10. Schembl14698168
11. Dtxsid40961323
12. F72098
13. Sodium .beta.-phenyl-.gamma.-hydroxybutyrate
14. Q27260724
15. Benzenepropanoic Acid, .beta.-(hydroxymethyl)-, Sodium Salt (1:1)
| Molecular Weight | 202.18 g/mol |
|---|---|
| Molecular Formula | C10H11NaO3 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 4 |
| Exact Mass | 202.06058849 g/mol |
| Monoisotopic Mass | 202.06058849 g/mol |
| Topological Polar Surface Area | 60.4 Ų |
| Heavy Atom Count | 14 |
| Formal Charge | 0 |
| Complexity | 167 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
ABOUT THIS PAGE
A Sodium 4-Hydroxy-3-Phenylbutanoate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sodium 4-Hydroxy-3-Phenylbutanoate, including repackagers and relabelers. The FDA regulates Sodium 4-Hydroxy-3-Phenylbutanoate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sodium 4-Hydroxy-3-Phenylbutanoate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Sodium 4-Hydroxy-3-Phenylbutanoate supplier is an individual or a company that provides Sodium 4-Hydroxy-3-Phenylbutanoate active pharmaceutical ingredient (API) or Sodium 4-Hydroxy-3-Phenylbutanoate finished formulations upon request. The Sodium 4-Hydroxy-3-Phenylbutanoate suppliers may include Sodium 4-Hydroxy-3-Phenylbutanoate API manufacturers, exporters, distributors and traders.
click here to find a list of Sodium 4-Hydroxy-3-Phenylbutanoate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Sodium 4-Hydroxy-3-Phenylbutanoate DMF (Drug Master File) is a document detailing the whole manufacturing process of Sodium 4-Hydroxy-3-Phenylbutanoate active pharmaceutical ingredient (API) in detail. Different forms of Sodium 4-Hydroxy-3-Phenylbutanoate DMFs exist exist since differing nations have different regulations, such as Sodium 4-Hydroxy-3-Phenylbutanoate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Sodium 4-Hydroxy-3-Phenylbutanoate DMF submitted to regulatory agencies in the US is known as a USDMF. Sodium 4-Hydroxy-3-Phenylbutanoate USDMF includes data on Sodium 4-Hydroxy-3-Phenylbutanoate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Sodium 4-Hydroxy-3-Phenylbutanoate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Sodium 4-Hydroxy-3-Phenylbutanoate suppliers with USDMF on PharmaCompass.
Sodium 4-Hydroxy-3-Phenylbutanoate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sodium 4-Hydroxy-3-Phenylbutanoate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sodium 4-Hydroxy-3-Phenylbutanoate GMP manufacturer or Sodium 4-Hydroxy-3-Phenylbutanoate GMP API supplier for your needs.
A Sodium 4-Hydroxy-3-Phenylbutanoate CoA (Certificate of Analysis) is a formal document that attests to Sodium 4-Hydroxy-3-Phenylbutanoate's compliance with Sodium 4-Hydroxy-3-Phenylbutanoate specifications and serves as a tool for batch-level quality control.
Sodium 4-Hydroxy-3-Phenylbutanoate CoA mostly includes findings from lab analyses of a specific batch. For each Sodium 4-Hydroxy-3-Phenylbutanoate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sodium 4-Hydroxy-3-Phenylbutanoate may be tested according to a variety of international standards, such as European Pharmacopoeia (Sodium 4-Hydroxy-3-Phenylbutanoate EP), Sodium 4-Hydroxy-3-Phenylbutanoate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sodium 4-Hydroxy-3-Phenylbutanoate USP).
LOOKING FOR A SUPPLIER?
